Invention Grant
US09073898B2 Crystalline form of an inhibitor of MDM2/4 and p53 interaction
有权
结晶形式的MDM2 / 4和p53相互作用的抑制剂
- Patent Title: Crystalline form of an inhibitor of MDM2/4 and p53 interaction
- Patent Title (中): 结晶形式的MDM2 / 4和p53相互作用的抑制剂
-
Application No.: US13988227Application Date: 2011-11-17
-
Publication No.: US09073898B2Publication Date: 2015-07-07
- Inventor: Joerg Berghausen , Haixia Ren
- Applicant: Joerg Berghausen , Haixia Ren
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michelle Han
- Priority: WOPCT/CN2010/078927 20101119
- International Application: PCT/EP2011/070385 WO 20111117
- International Announcement: WO2012/066095 WO 20120524
- Main IPC: A61K31/496
- IPC: A61K31/496 ; C07D401/12
Abstract:
A crystalline form of (S)-1-(4-Chloro-phenyl)-7-isopropoxy-6-methoxy-2-(4-{methyl-[4-(4-methyl-3-oxo-piperazin-1-yl)-trans-cyclohexylmethyl]-amino}-phenyl)-1,4-dihydro-2H-isoquinolin-3-one, which is useful in the treatment of a disease or disorder associated with the interaction between p53, or variants thereof, and MDM2 and/or MDM4, or variants thereof, respectively.
Public/Granted literature
- US20130245036A1 CRYSTALLINE FORM OF AN INHIBITOR OF MDM2/4 AND P53 INTERACTION Public/Granted day:2013-09-19
Information query
IPC分类:
